Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

Treatment strategies of HCV patients in different medical conditions


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 5,886

Availability: In stock

  • Product Description

Currently approved antiviral therapy for HCV is PEG-IFNα plus RBV for 48 weeks in genotypes 1 and 4, and for 24 weeks for genotypes 2 and 3. Acute HCV infection is usually asymptomatic and difficult in diagnosis. Occult HCV infection is a new entity that should be taken into account for the diagnosis of patients with elevated liver enzymes or liver disease of unknown aetiology. HCV infection causes many renal diseases especially membrano-proliferative glomerulonephritis type 1 which caused mostly by type II mixed cryoglobulinaemia. HCV infection especially genotype 3 carries higher risk of insulin resistance and hepatic steatosis which in turn help progression of liver diseases. HBV/HCV co-infection is not uncommon, especially within areas of high prevalence of HBV. Dual infections represent unique management challenges. This book is highlight the different treatment modalities of HCV patients in different medical conditions.

Product Specifications
SKU :COC84258
AuthorAhmed Sultan,Fayza Azzam and Shahira El-Etreby
Number of Pages264
Publishing Year2013-01-13T00:00:00.000
Edition1 st
Book TypeMedicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-10-08 00:00:00